Trial NCT05312372

View at ClinicalTrials.gov 
Org. Study IDs: CL1-95033-002
Secondary IDs: 2022-000250-29

Last trial update was posted on 2022-12-07

MeSH Interventions

Paclitaxel

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Esophageal Squamous Cell Carcinoma

Other Conditions


Stopping Reasons

Strategic development reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID